Ameriprise Financial »

Keros Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 120k 15.82
2025-06-30 $1.3M 99k 13.35